*Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2; DiboterminAlfa) in the Management of Open Tibial Fractures: A Prospective, Randomized, Controlled Study in 450 Patients
Share
Authors
Robert J. Feibel, MD, The Ottawa Hospital-GeneralCampus, Ottawa, ON, Canada; Cristina I. Csimma, RPh, MHP; Alexandre Valentin-Opran, MD, BESTT Study Group,